title: Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
authors.affiliation: Department of Surgery, LMU Munich, Klinikum Grosshadern, FRG.
authors.forename: M
authors.initials: M
authors.lastname: Schilling
authors.forename: S
authors.initials: S
authors.lastname: Schleibner
authors.forename: D
authors.initials: D
authors.lastname: Abendroth
authors.forename: W D
authors.initials: WD
authors.lastname: Illner
authors.forename: H
authors.initials: H
authors.lastname: Schneeberger
authors.forename: W
authors.initials: W
authors.lastname: Land
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011239:Prednisolone / Q000627:therapeutic use*
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine